Dyne Therapeutics (DYN) is down -13.7%, or -$3.05 to $19.15.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DYN:
- Dyne Therapeutics price target raised to $50 from $46 at Morgan Stanley
- Dyne Therapeutics price target raised to $23 from $21 at Bernstein
- Dyne Therapeutics Amends Loan Agreement for $50 Million
- Dyne Therapeutics offers to sell $300M in common stock
- Dyne Therapeutics price target raised to $60 from $46 at H.C. Wainwright